SecBot SecBot
8-K ·Filed May 13, 2026

IRWD

IRONWOOD PHARMACEUTICALS INC
MIXED
Impact 6/10
Horizonweeks Processed6mo ago SEC0001104659-26-059814
8-K context-dependent: Items 5.02
Actionable Insight ◆ Mixed

Monitor for permanent CFO appointment and outcome of June 16, 2026 annual meeting proxy contest. The leadership change amid governance uncertainty could pressure the stock near-term.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.68
T+0 close · May 13, 2026 · via day close
Latest settled
+17.39%
T+60 · $4.32
Vs SPY
+12.95%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 13 $3.68entry
  2. T+1 · 6mo ago −0.27%α −1.05% · $3.67
  3. T+5 · 6mo ago −0.27%α +0.89% · $3.67
  4. T+20 · 5mo ago −1.36%α −0.75% · $3.63
  5. T+60 · 3mo ago +17.39%α +12.95% · $4.32
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

IRWD CFO Gregory Martini resigned effective May 15, 2026, with Ronald Silver serving as interim CFO. The resignation is not due to financial reporting disagreements, but comes 15 days after a DEFA14A proxy filing indicating a contested board election. The combination of CFO departure and ongoing proxy fight elevates uncertainty around leadership and governance.

Key Facts

  • CFO Gregory Martini resigned effective May 15, 2026
  • Resignation not due to disagreement on financial reporting
  • Ronald Silver, SVP Corporate Controller & CAO, appointed interim CFO
  • DEFA14A filed April 28, 2026 signals contested proxy election
  • No permanent CFO replacement announced

Financial Impact

Not specified

Risk Factors

  • Prolonged CFO vacancy or difficulty attracting permanent CFO
  • Proxy contest outcome may lead to board overhaul and strategic shifts
  • Potential for additional executive departures

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-059814
Document: 0001104659-26-059814-index-headers.html0001104659-26-059814
Document: 0001104659-26-059814-index.html0001104659-26-059814
Document: 0001104659-26-059814.txt0001104659-26-059814

Track record

13 reports on IRWD

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +20.35% at T+5 after the Nov 5, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $4.88 Now $4.85 −0.51% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $4.84 Now $4.85 +0.21% settles Dec 15
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.81 Now $4.85 +0.83% settles Dec 9
  4. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $4.81 Now $4.85 +0.83% settles Dec 9
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $4.03 Now $4.85 +20.35% settles Dec 4
  6. Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $3.61 Now $4.85 +34.35% settles Nov 25
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $3.50 to $4.85 Now $4.85 +38.57% ▲ +38.57% +39.73% vs SPY
  8. Aug 6, 202614w ago 8-K Bullish 7/10 Entry $4.26 to $4.29 Now $4.85 +13.85% ▲ +0.70% +0.10% vs SPY
  9. May 13, 202626w ago 8-K Mixed 6/10 Viewing Entry $3.68 to $3.63 Now $4.85 +31.79% ▼ −1.36% −0.75% vs SPY
  10. May 7, 202627w ago 8-K Bullish 7/10 Entry $4.17 to $3.24 Now $4.85 +16.31% ▼ −22.30% −25.44% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 8h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026